Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial - Quiz - MDSpire

Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial

  • By

  • Justin R. Ortiz

  • Drishya Kurup

  • Adam C. Kaufman

  • Sabrine Ben Hamed

  • Allison M. LaRocco

  • Kirsten E. Lyke

  • Sarah M. Litts

  • Shrimati Datta

  • Yuanyuan Liang

  • Megan F. McGilvray

  • Jeannie A. Losignor

  • Jennifer J. Oshinsky

  • Kari V. Palmer

  • Ifayet PL Johnson-Mayo

  • Gabrielle Scher

  • Uthra Balakumar

  • Anisha Chandwani

  • Rekha R. Rapaka

  • Meagan E. Deming

  • Joel V. Chua

  • Christoph Wirblich

  • Wilbur H. Chen

  • Kathleen M. Neuzil

  • Marcela F. Pasetti

  • Matthias J. Schnell

  • June 9, 2026

  • 0 min

Share

Original Source(s)

Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial

  • by Justin R. Ortiz, Drishya Kurup, Adam C. Kaufman, Sabrine Ben Hamed, Allison M. LaRocco, Kirsten E. Lyke, Sarah M. Litts, Shrimati Datta, Yuanyuan Liang, Megan F. McGilvray, Jeannie A. Losignor, Jennifer J. Oshinsky, Kari V. Palmer, Ifayet PL Johnson-Mayo, Gabrielle Scher, Uthra Balakumar, Anisha Chandwani, Rekha R. Rapaka, Meagan E. Deming, Joel V. Chua, Christoph Wirblich, Wilbur H. Chen, Kathleen M. Neuzil, Marcela F. Pasetti, Matthias J. Schnell

  • June 9, 2026

Related Content

Acute pancreatitis temporally associated with COVID-19 pneumonia in a patient with post-tuberculosis chronic pulmonary aspergillosis: a case report

De novo NFKBIA variants within the N-terminal hotspot: consistent immunophenotype and divergent clinical presentations

Incidence and clinical characterization of retinal detachment in acute retinal necrosis: a global federated database analysis